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Association of Accelerometry-Measured Physical Activity and
Cardiovascular Events in Mobility-Limited Older Adults: The LIFE
(Lifestyle Interventions and Independence for Elders) Study
Shannon K. Cochrane, BS; Shyh-Huei Chen, PhD; Jodi D. Fitzgerald, BS; John A. Dodson, MD, MPH; Roger A. Fielding, PhD;
Abby C. King, PhD; Mary M. McDermott, MD; Todd M. Manini, PhD; Anthony P. Marsh, PhD; Anne B. Newman, MD, MPH; Marco Pahor, MD;
Catrine Tudor-Locke, PhD; Walter T. Ambrosius, PhD; Thomas W. Buford, PhD; for the LIFE Study Research Group*
Background-—Data are sparse regarding the value of physical activity (PA) surveillance among older adults—particularly among
those with mobility limitations. The objective of this study was to examine longitudinal associations between objectively measured
daily PA and the incidence of cardiovascular events among older adults in the LIFE (Lifestyle Interventions and Independence for
Elders) study.
Methods and Results-—Cardiovascular events were adjudicated based on medical records review, and cardiovascular risk factors
were controlled for in the analysis. Home-based activity data were collected by hip-worn accelerometers at baseline and at 6, 12,
and 24 months postrandomization to either a physical activity or health education intervention. LIFE study participants (n=1590;
age 78.95.2 [SD] years; 67.2% women) at baseline had an 11% lower incidence of experiencing a subsequent cardiovascular
event per 500 steps taken per day based on activity data (hazard ratio, 0.89; 95% confidence interval, 0.84–0.96; P=0.001). At
baseline, every 30 minutes spent performing activities ≥500 counts per minute (hazard ratio, 0.75; confidence interval, 0.65–0.89
[P=0.001]) were also associated with a lower incidence of cardiovascular events. Throughout follow-up (6, 12, and 24 months),
both the number of steps per day (per 500 steps; hazard ratio, 0.90, confidence interval, 0.85–0.96 [P=0.001]) and duration of
activity ≥500 counts per minute (per 30 minutes; hazard ratio, 0.76; confidence interval, 0.63–0.90 [P=0.002]) were significantly
associated with lower cardiovascular event rates.
Conclusions-—Objective measurements of physical activity via accelerometry were associated with cardiovascular events among
older adults with limited mobility (summary score >10 on the Short Physical Performance Battery) both using baseline and
longitudinal data.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01072500. ( J Am Heart Assoc. 2017;6:
e007215. DOI: 10.1161/JAHA.117.007215.)
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C ardiovascular disease (CVD) is the leading cause ofdeath in the United States and worldwide.1 In the United
States, more than 2200 Americans die every day from
cardiovascular-related causes, and persons older than
65 years account for nearly 80% of these deaths.2 Older
adults also account for nearly 75% of cardiovascular-related
healthcare expenditures.3 Notably, these personal and public
health costs are likely to dramatically increase in coming
years as the number of Americans 65 years and older is
expected to double by the year 2050.4
Physical activity (PA) is known to improve health and
decrease the risk of developing CVD in a variety of
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populations.5,6 However, less is known regarding the influ-
ence of habitual or daily PA in preventing cardiovascular
events among older adults. In particular, data are lacking
regarding the influence of daily PA on cardiovascular risk
among older adults with mobility limitations that restrict the
ability to engage in PA.
Although associations between the quantity of PA and
cardiovascular risk factors have been reported in older
adults, few have made these connections using objective
measurements of PA. To date, most studies have relied on
self-reported measures of PA, which commonly misclassify
the volume and/or intensity of PA.6 Although PA has been
shown to have an inverse relationship with cardiovascular
risk factors and morbidity,4 it is unknown whether partici-
pation in activity reduces cardiovascular incidence in popu-
lations of older adults displaying habitually low levels of PA.
Prospective studies to date have largely focused on increas-
ing exercise participation, although formal exercise interven-
tions have been insufficient in reducing the incidence of
cardiac events in this population.7 However, few studies have
utilized objective measurements using accelerometry to
evaluate cardiovascular risk in older adults. The benefits of
using accelerometry as an objective means to measure
activity levels in older adults have been previously
explored.8,9 Most notably, these include triaxial measure-
ment of movement in 3 orthogonal directions, so as to
capture both linear and rotational movements, and measure-
ment of both duration and intensity of activity. These
noninvasive and objective measurement devices do not
require participants to undergo training, can be worn without
interfering with an individual’s daily activities, and precisely
measure low levels of activity.
We previously evaluated the association of baseline activity
patterns (via triaxial accelerometry) of participants in the LIFE
(Lifestyle Interventions and Independence for Elders) study
with predicted cardiovascular risk using a Framingham risk
prediction model for hard coronary heart disease.10 This study
found that every 25 to 30 min/d spent being sedentary—
defined by <100 accelerometry counts per minute—was
associated with a 1% higher predicted risk of myocardial
infarction (MI) or coronary-related death. Conversely, daily
time spent in activities registering 100 to 499 counts per
minute was associated with lower predicted hard coronary
heart disease risk. Every 30 to 35 minutes of inactivity in this
range was also associated with a 1-mg/dL lower circulating
high-density lipoprotein cholesterol concentration. Somewhat
surprisingly, however, the mean intensity of daily activities
was not associated with predicted cardiovascular risk in this
population. These data also indicated a significant interaction
between sex and activity count for those without CVD, as
counts per minute were related to hard coronary heart
disease risk in women but not men.
To our knowledge, our prior study was the first to report
associations of habitual PA with cardiovascular risk in a
clinically representative population of older adults with
mobility limitations. However, the cross-sectional nature of
the study prevented the ability to draw causal inferences and
provided only a projection of cardiovascular risk. Therefore,
the overarching objective of the present study is to expand on
these prior findings using longitudinal assessment of
accelerometry-based PA patterns and the observation of
cardiovascular events among this population. This study
evaluates the extent to which objective measures of daily PA
assessed via accelerometry at baseline and measured longi-
tudinally (0, 6, 12, and 24 months) are associated with
cardiovascular events among mobility-limited older adults
who participated in the LIFE study.
Methods
Study Overview
The data sets generated and analyzed during the current
study are available in the LIFE study repository at https://
www.thelifestudy.org/public/index.cfm, and are available
Clinical Perspective
What Is New?
• The use of initial and recurring accelerometry measure-
ments may provide useful metrics regarding the impact of
older adults’ daily lifestyle on cardiovascular risk.
• The present findings suggest that even a single baseline
assessment can provide useful information regarding
cardiovascular event incidence that can aid in targeting
modifiable risk factors.
• This study is one of the first to use accelerometry to explore
activity levels and health status among older adults with
mobility limitations.
What Are the Clinical Implications?
• Accelerometry measures could serve as an objective,
noninvasive, risk monitoring tool for the older adult
population.
• Identification of volume and/or intensity of daily physical
activity could clinically translate into initial physical activity
recommendations and long-term physical activity monitor-
ing and modification.
• Individuals should talk to their healthcare provider before
initiating an individual exercise program and discuss what
activity levels are recommended for their current health
status.
• These findings contribute to an overall wellness recommen-
dation for increased low-level physical activity.
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from the LIFE study investigators upon reasonable request.
The LIFE study was a phase 3 multicenter randomized
controlled trial designed to evaluate the efficacy of a long-
term PA intervention compared with a successful aging health
education (HE) intervention for reducing the incidence of
major mobility disability among mobility-limited older adults.
Briefly, the LIFE study team randomized 1635 participants
from 8 locations throughout the United States and imple-
mented the trial between February 2010 and December 2013.
Details about specific study design and implementation of the
LIFE study have been previously reported.11,12 Institutional
review boards at all participating sites approved the study
protocol, and written informed consent was obtained from all
study participants. The trial was monitored by a data and
safety monitoring board appointed by the National Institute on
Aging and was registered at http://www.clinicaltrials.gov
(NCT01072500) before participant recruitment.
Participants and Study Entry
Details about specific recruitment strategies and inclusion
criteria for the LIFE study have been previously reported.11,12
Briefly, participants were eligible for the study if they: (1) were
between the ages of 70 and 89 years, (2) were at high risk for
mobility disability based on objectively measured lower-
extremity functional limitations, (3) were able to walk
400 m in ≤15 minutes, (4) reported spending <20 min/wk
performing moderate to vigorous PA, (5) displayed satisfac-
tory cognitive function, and (6) were able to safely participate
in the PA and HE interventions. A thorough medical screening
was performed to ensure the safety of potential participants.
The screening included an initial telephone screening, a
prescreening visit where the study was presented to the
participant, a question and answer session, a prescreening
consent form, tests of physical performance, and the
Community Healthy Activities Model Program for Seniors
(CHAMPS) PA questionnaire13 to confirm sedentary lifestyle.
This questionnaire assesses engagement in moderate-inten-
sity activities as well as engagement in all specified physical
activities to discern the frequency and duration of PA usually
undertaken by an older adult.
Study Interventions
Participants were randomized to either the PA or HE
intervention via a secure, web-based data management
system using a permuted block algorithm (with random block
lengths) stratified by field center and sex. Both intervention
groups received an initial individual 45-minute face-to-face
question and answer session, in which a health educator
explained the intervention, communicated expectations, and
answered questions.14
The PA intervention involved walking (with a goal of
150 min/week), strength, flexibility, and balance training.11
The intervention included attendance at 2 center-based visits
per week and home-based activity 3 or 4 times per week for
the duration of the study. A protocol was in place to restart
the intervention for the participants who suspended PA for
medical reasons. The PA intervention sessions were individ-
ualized and progressed toward a goal of 30 minutes of
walking daily at moderate intensity, 10 minutes of primarily
lower extremity strength training by means of ankle weights
(2 sets of 10 repetitions), 10 minutes of balance training, and
large muscle group flexibility exercises. The participants
began with lighter intensity and gradually increased the
intensity over the first 2 to 3 weeks of the intervention. The
Borg scale of self-perceived exertion,15 which ranges from 6
to 20, was used to measure intensity of activity. Participants
were asked to walk at an intensity of 13 (activity perception
“somewhat hard”), and lower extremity strengthening exer-
cises were performed at an intensity of 15 to 16. Further
details regarding the training program are available else-
where.11,13
Participants in the HE intervention were assigned to attend
small group sessions weekly for the first 26 weeks and
monthly thereafter. The educational sessions included topics
relevant to older adults and were intended to increase
awareness relative to a variety of health topics including how
to effectively negotiate the healthcare system, medications,
foot care, preventive services and screenings recommended
at different ages, how to travel safely, and nutrition. Each
session concluded with a short instructor-led program (5–
10 minutes) of upper extremity stretching exercises. Infor-
mation relative to PA was purposely avoided, with the
exception of a PA brochure presented to participants during
the first HE session.
Accelerometry
Daily PA was objectively measured using a hip-worn, solid-
state triaxial accelerometer (ActiGraph GT3X) at 0, 6, 12, and
24 months. Participants were asked to wear the device at all
times—except while bathing, sleeping at night, or swimming
—for a minimum of 7 consecutive days. Movement was
captured along the vertical axis in 1-second epochs, and
nonwear time was classified using a previously published
algorithm16 that flags areas where there is a 90-minute time
window of zero counts per min after allowing a 2-minute
interval of nonzero counts for artifactual movement detection.
We limited our analyses at each time point (0, 6, 12, and
24 months) to participants who wore the device for at least
10 hours per day for a minimum of 3 days. Participants with
valid data for at least one time point were included in the
present analyses. Currently, there are no well-accepted,
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evidence-based accelerometry cut points for PA in mobility-
limited older adults. Therefore, the cut point for PA was
chosen based on current best practices from the literature.
Sedentary behavior was defined as <100 counts per minute17
and PA was categorized as activities registering ≥100 counts
per minute. Furthermore, PA was divided into 2 incremental
intensity categories identified by accelerometer-detected
ranges of 100 to 499 counts per minute and activities
registering ≥500 counts per minute.
Assessment of Cardiovascular Events
At each 6-month contact, participants (or a proxy informant
if the participant was not available) were questioned about
all hospitalizations since the last visit. Hospital records
were obtained to abstract for the standard criteria for the
primary and secondary outcomes, blinded to intervention
assignment. The primary outcome in the LIFE study was
major mobility disability, while total CVD was a predefined
secondary outcome and included MI, silent MI, hospitalized
angina, congestive heart failure, revascularization with
bypass surgery or percutaneous angioplasty, aortic aneur-
ysm, peripheral artery disease, stroke, and transient
ischemic attack. Records and abstraction forms were sent
to the coordinating center for central review by 2 physician-
investigators, with adjudication as definite, probable, or not
confirmed by 2 reviewers. If there were differences
between reviewers, cases were adjudicated by consensus
of the full committee. Only definite events were included in
this report.
Reports of death were tracked through regular surveillance
and death certificates were obtained to supplement the
hospital record review. Silent MI was assessed by ECGs
obtained at 18 and 36 months and read at a central reading
center. The time from randomization date to the first
cardiovascular event, fatal or nonfatal, was used to define
incidence during the trial. Analyses were conducted and
assessed for the overall sample and stratified according to
history versus no history of CVD.
Statistical Analysis
Baseline characteristics including randomization, demo-
graphic characteristics, and self-reported disease history
were summarized using means (SDs) for continuous measures
and counts (percentages) for discrete measures. A series of
Cox proportional hazards regression models stratified by field
center and sex were used to explore the association between
accelerometry measures and cardiovascular events. Event
time was defined as the time from randomization to the initial
CVD event and censoring time as the time from randomization
to the last assessment or death.
Five baseline daily accelerometry measures of interest
were included in this analysis one at a time: total activity
counts, total step counts, sedentary time (minutes of activity
count <100 counts per minute), minutes of activity count
≥500 counts per minute, and 30-minute peak cadence. Model
1 adjusted for randomization and accelerometer wear time.
Model 2 added race, age, education, marital status, and
whether a participant lived alone. Model 3 further added
history of diabetes mellitus, history of CVD, use of antihyper-
tensive drugs, and use of lipid-lowering drugs. Finally, Model 4
further added systolic blood pressure, diastolic blood pres-
sure, ankle-brachial index, and Pittsburgh Sleep Quality Index
(PSQI) scores. The analyses were performed using R (survival
package).18 Considering multiple comparisons, a conservative
Bonferroni correction with P<0.01 (P=0.05/5 for 5 individual
accelerometry measures).
To study how different levels of PA were associated with
cardiovascular events, 2 intensity levels: (1) minutes of
activity counts 100 to 499 counts per minute, and (2) minutes
of activity counts ≥500 counts per minute, were included in a
model simultaneously. Because the model was adjusted for
accelerometer wear time, the third PA intensity level, (3)
sedentary time, was not fitted to avoid singularity. The
interaction between the 2 intensity levels was also tested. The
interaction was removed from the model when not significant.
Each accelerometry measure was also defined as a time-
dependent variable and refitted to allow for time-dependent
covariates. Time-varying covariate models used accelerometry
data at baseline to assess association with CVD events in the
interval from 0 to 6 months; 6-month PA data for associations
with CVD events during 6 to 12 months; 12-month PA data
for associations with CVD events during 12 to 24 months;
and 24-month PA data for associations with CVD events at
>24 months. Additional analyses included: (1) testing the
interaction between each PA measure and randomization, (2)
a sensitivity analysis to evaluate the influence of CVD history
on outcomes, and (3) the evaluation of the association
between self-reported moderate-intensity PA as measured by
the CHAMPS questionnaire and cardiovascular events.
Results
Data from a total of 1590 LIFE participants were included in
the present study. Forty-five participants did not have
sufficient valid accelerometry data, and were therefore
excluded from the present analysis. The mean (SD) age of
included participants was 78.95.2 years, 67.2% were
women, and 23.6% were racial/ethnic minorities. Just over a
third of participants were married (35.9%), and the majority of
participants reported having a college education (63.8%). In
general, participants were cognitively intact as evidenced by
scores on the Modified Mini-Mental State Examination (3MS)
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(91.75.4 points), showed low levels of depressive symptoms
according to Center for Epidemiologic Studies Depression
Scale (CESD) scores (8.57.8), and had relatively poor sleep
quality according to PSQI scores (5.93.8). Based on
self-report, 7.9% of participants experienced a previous MI,
4.3% reported a history of congestive heart failure, and 19.6%
reported a history of other cardiovascular conditions. For the
present study, a total of 234 cardiovascular events were
included (HE:PA=113:121) for a total incidence of 14.7%.
Additional detail regarding participant demographic charac-
teristics is provided in Table 1.
At baseline, participants wore accelerometers for a mean
of 7.953.24 valid wear days and 837.1111.1 min/d (ie,
≥10 h/d). They spent 647116 min/d of their baseline wear
time (647/837=77%) being sedentary (ie, <100 counts per
minute). The remaining (nonsedentary) time was spent in
activity registering 100 to 499 counts per minute
(13743 min/d) with a smaller portion (5338 min/d)
spent performing activities registering ≥500 counts per
minute. Participants also accrued 26811475 steps per
day with a peak average cadence of 34.817.2 steps per
30 minutes during the baseline measurement period.
The association of baseline accelerometry measures with
incidence of cardiovascular events is shown in Table 2
(individual PA). Most notably, every 30 minutes spent engag-
ing in activities registering ≥500 counts per minute was
associated with a 25% decrease in cardiovascular event risk
(P=0.001). At baseline, participants had an 11% lower chance
of experiencing a subsequent cardiovascular event per
500 steps taken per day (P=0.001). Meanwhile, every
30 min/d spent being sedentary was associated with a 13%
increase in risk of cardiovascular events (P=0.002) after
adjustment. Total number of activity counts per day was also
negatively associated with the risk of cardiovascular event
(P=0.001), while peak cadence of activity was not significantly
associated with cardiovascular event risk. There were no
significant interactions of any of these accelerometry mea-
sures with the randomized arm (all P values >0.05). The
Table 1. Demographic Characteristics of Study Participants
Full Sample
(N=1590)
PA Arm
(n=790)
HE Arm
(n=800)
Women 1069 (67.2) 525 (66.5) 544 (68.0)
Age 78.95.2 78.75.2 79.15.2
Nonwhite 375 (23.6) 200 (25.3) 175 (21.9)
Living alone 780 (49.1) 371 (47.0) 409 (51.1)
Married 571 (35.9) 288 (36.5) 283 (35.4)
Education: college or higher 1015 (63.8) 497 (62.9) 518 (64.8)
CESD score 8.57.8 8.37.7 8.87.9
PSQI score 5.93.8 5.93.8 5.93.8
3MS score 91.75.4 91.75.5 91.75.3
Self-reported history of cardiovascular-related conditions
Myocardial infarction 125 (7.9) 59 (7.5) 66 (8.3)
Congestive heart failure 69 (4.3) 25 (3.2) 44 (5.5)
Stroke 106 (6.7) 55 (7.0) 51 (6.4)
Lung disease 246 (15.5) 124 (15.7) 122 (15.3)
Diabetes mellitus 397 (25.0) 187 (23.7) 210 (26.3)
Other self-reported CVD 311 (19.6) 150 (19.0) 161 (20.1)
Smoking status
Current 703 (44.2) 371 (47.0) 332 (41.5)
Former 47 (3.0) 24 (3.0) 23 (2.9)
Data are expressed as meanSD or number (percentage). 3MS indicates Modified Mini-
Mental State Examination; CESD, Center for Epidemiologic Studies Depression Scale;
CVD, cardiovascular disease; HE, health education; PA, physical activity; PSQI, Pittsburgh
Sleep Quality Index.
Table 2. Association of Baseline Accelerometry Measures With Cardiovascular Event Risk
Accelerometry Measure Model 1 Model 2 Model 3 Model 4
Individual Total step counts (500 steps) 0.86 (0.80–0.91)* 0.86 (0.80–0.92)* 0.89 (0.83–0.95)* 0.89 (0.84–0.96)*
Sedentary time (30 min) 1.19 (1.10–1.27)* 1.18 (1.09–1.27)* 1.14 (1.06–1.23)* 1.13 (1.04–1.22)*
Min/d ≥500 counts/min (30 min) 0.67 (0.57–0.79)* 0.68 (0.58–0.80)* 0.74 (0.63–0.87)* 0.75 (0.65–0.89)*
Total activity counts (10 000 counts) 0.90 (0.87–0.94)* 0.91 (0.87–0.95)* 0.93 (0.89–0.97)* 0.93 (0.89–0.97)*
Peak 30-min cadence, steps per min 0.98 (0.97–0.99)* 0.98 (0.97–0.99)* 0.98 (0.97–1.00)* 0.99 (0.97–1.00)*
Joint Min/d 100 to 499 counts per min (30 min) 0.98 (0.85–1.12) 0.97 (0.85–1.12) 0.97 (0.85–1.12) 0.99 (0.85–1.14)
Min/d ≥500 counts per min (30 min) 0.68 (0.57–0.83)† 0.70 (0.57–0.85)† 0.75 (0.62–0.92)† 0.76 (0.62–0.93)†
Data are expressed as hazard ratios (95% confidence intervals). Sedentary time was defined as minutes per day <100 counts per minute. All models adjusted for accelerometer wear time.
Model 1 stratified for site and sex, and adjusted for randomization. Model 2 adjusted for model 1, race, age, education, living alone, and marital status. Model 3 adjusted for model 2,
diabetes mellitus, cardiovascular disease, and antihypertensive use. Model 4 adjusted for model 3, ankle-brachial index, systolic and diastolic blood pressure, and Pittsburgh Sleep Quality
Index score.
*If P<0.01 (Bonferroni corrected for multiple accelerometry measures) for individual physical activity measure model fit.
†If P<0.05 for joint physical activity measures model fit.
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models were fitted with 2 levels of activities at baseline,
minutes of activity 100 to 499 counts per minute, and
minutes of activity ≥500 counts per minute, simultaneously.
Minutes of activity ≥500 counts per minute was negatively
associated with cardiovascular risk after adjusting for minutes
of activity 100 to 499 counts per minute and other covari-
ates, while minutes of activity 100 to 499 counts per minute
was not associated with cardiovascular event risk, as shown
in Table 2 (joint PA). The interaction between minutes of 100
to 499 counts per minute and ≥500 counts per minute was
not significantly associated.
Across all data collection visits, participants spent
648114 min/d of their wear time (78.2%) being sedentary
(ie, <100 counts per minute). The remaining time was spent
in activity registering 100 to 499 counts per minute
(13144 min/d) and ≥500 counts per minute
(5135 min/d). Participants also accrued 26251545 steps
per day. Accelerometry data across study visits are shown for
all participants in Table 3.
The longitudinal association of accelerometry measures
with cardiovascular events based on time-varying models is
shown in Table 4. Using these longitudinal data, minutes per
day spent engaging in activities registering ≥500 counts per
minute had the strongest association with cardiovascular
events (P=0.002). In addition, every 500 steps taken were
associated with a 10% decrease in cardiovascular event risk
(P=0.001), as well as a 6% decrease in cardiovascular event
risk for every 10 000 activity counts recorded (P=0.003).
There were no significant interactions of any accelerometry
measures with treatment group (all P values >0.05). More-
over, sensitivity analyses revealed that CVD history did not
influence associations of any PA exposures with cardiovas-
cular events (all P values >0.05). Lastly, self-reported PA via
the CHAMPS questionnaire was not significantly associated
with events in either the baseline model (hazard ratio, 1.00;
95% confidence interval, 0.97–1.04) or the longitudinal model
(hazard ratio, 0.99; confidence interval, 0.96–1.02). Similar to
the baseline PA joint model, minutes of activity counts
≥500 counts per minute was negatively associated with
cardiovascular event risk, while minutes of activity counts 100
to 499 counts per minute was not associated with cardio-
vascular event risk. However, the interaction between minutes
of 100 to 499 counts per minute and ≥500 counts per minute
was significant for cardiovascular event incidence, as shown
in Table 4 (Joint PA).
Discussion
The national burden of morbidity and mortality caused by CVD
events remains high,2 calling for cost-efficient and effective
preventative measures. Regular engagement in PA is an
important factor in maintaining cardiovascular health, and as Ta
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such, several scientific and public health bodies have created
minimum PA guidelines for improving cardiovascular
health.6,19,20 However, despite these guidelines, questions
remain about the proper prescription of PA among several
populations—including older adults with mobility limitations.
In fact, although these guidelines were created to apply to all
adults, the gradations of cardiovascular risk among mobility-
limited older adults who may be unable to meet these
recommendations are unknown. Thus, objective measure-
ments of PA, such as those obtained by accelerometers,
which accurately classify the volume and/or intensity of PA,
may assist in refining PA recommendations for this
population.
The primary finding of this study is that objective
measurement of PA via accelerometry was significantly
associated with incidence of cardiovascular events among
older adults with limited mobility. These findings suggest that
the use of initial and recurring accelerometry measurements
may provide useful metrics regarding the impact of seniors’
daily lifestyle on cardiovascular risk. This noninvasive mea-
sure does not require participant training and provides
objective data for monitoring and assessing CVD risk. In fact,
the present findings suggest that even a single baseline
assessment can provide useful information regarding cardio-
vascular event incidence, which can aid in targeting modifi-
able risk factors. The aim for future use of accelerometry data
includes identification of likelihood of experiencing a cardio-
vascular event based on habitual activity levels, and not the
reduction of cardiovascular risk through the use of an exercise
intervention.
Notably, the present study did not indicate a significant
interaction between accelerometry measures and the ran-
domized arm in relation to cardiovascular events. This
finding is in line with results from recent large, longitudinal
clinical trials—including the LIFE study—indicating limita-
tions in structured activity interventions for reducing CVD
incidence among high-risk populations.7,21 It remains possi-
ble that responses to interventions may not be observed
because baseline levels of activity as even small amounts of
daily activity may provide CVD protection—although more
studies in this area are needed to confirm this hypothesis. In
addition, the present study did not indicate an association of
self-reported PA from the CHAMPS survey with CVD. As has
been previously explored,7 this could be attributable to a
lack of sensitivity from self-report as well as a potential
issue of intensity in the way in which CHAMPS is graded.
While accelerometry is capable of accurately capturing low
levels of PA, the CHAMPS survey may not be graded in a
way that allows for a precise measurement of low-level
activity.
Study Strengths and Limitations
The present study had several strengths including a clinically
relevant study population, multisite design, relatively large
sample size, and use of an objective measurement of PA.
Limitations of this analysis include missing accelerometry
data, the lack of generalizability of conclusions to populations
other than older, mobility-limited adults, and the potential for
residual confounding.
Still, these data do suggest that accelerometry measures
could serve as an objective, noninvasive, risk monitoring tool
for the older adult population. Identification of volume and/or
intensity of daily PA could clinically translate into initial PA
recommendations, and long-term PA monitoring and modifi-
cation. Individuals should talk to their healthcare provider
before initiating an individual exercise programs and discuss
what activity levels are recommended for their current health
Table 4. Association of Longitudinal, Time-Varying, Accelerometry Measures With Cardiovascular Event Risk
Accelerometry Measure Model 1 Model 2 Model 3 Model 4
Individual Total step counts (500 steps) 0.87 (0.82–0.92)* 0.87 (0.82–0.92)* 0.89 (0.84–0.95)* 0.90 (0.85–0.96)*
Sedentary time (30 min) 1.15 (1.07–1.24)* 1.15 (1.07–1.24)* 1.11 (1.03–1.20)* 1.10 (1.02–1.19)*
Min/d ≥500 counts per min (30 min) 0.68 (0.58–0.80)* 0.68 (0.57–0.81)* 0.73 (0.62–0.81)* 0.76 (0.63–0.90)*
Total activity counts (10 000 counts) 0.92 (0.88–0.95)* 0.92 (0.88–0.95)* 0.93 (0.89–0.97)* 0.94 (0.90–0.98)*
Peak 30-min cadence, steps per min 0.98 (0.97–0.99)* 0.98 (0.97–0.99)* 0.98 (0.97–0.99)† 0.98 (0.97–0.99)*
Joint Min/d 100 to 499 counts per min (30 min) 0.92 (0.77–1.09) 0.91 (0.77–1.08) 0.92 (0.78–1.10) 0.92 (0.77–1.10)
Min/d ≥500 counts per min (30 min) 0.37 (0.23–0.60)† 0.37 (0.23–0.61)† 0.42 (0.25–0.71)† 0.40 (0.24–0.68)†
Interaction 1.12 (1.03–1.23)† 1.13 (1.03–1.23)† 1.11 (1.01–1.22)† 1.13 (1.03–1.24)†
Data are expressed as hazard ratios (95% confidence intervals). Sedentary time is defined as minutes per day <100 counts per minute. All models adjusted for accelerometer wear time.
Model 1 stratified for site and sex, and adjusted for randomization. Model 2 adjusted for model 1, race, age, education, living alone, and marital status. Model 3 adjusted for model 2,
diabetes mellitus, cardiovascular disease, and antihypertensive use. Model 4 adjusted for model 3, ankle-brachial index, systolic and diastolic blood pressure, and Pittsburgh Sleep Quality
Index score.
*If P<0.01 (Bonferroni corrected for multiple accelerometry measures) for individual physical activity measure model fit.
†If P<0.05 for joint physical activity measures model fit.
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status. While individuals in this population should be
discussing individual exercise programs with a healthcare
provider before initiating an exercise program, these findings
contribute to an overall wellness recommendation for
increased low-level PA. An increase in habitual activity could
be a way to decrease time spent sedentary and allow
individuals to benefit from the health advantages of engage-
ment in low-level PA. Clinically, healthcare professionals can
discuss the benefits of low-level activity outside of formal
exercise. This assessment tool may also allow researchers to
target additional modifiable risk factors in combination with
adjustments in daily activity levels. Presently, however, the
lack of established guidelines for classifying accelerometry
measures in this population limits the ability to immediately
translate these findings into public health recommendations.
This study is one of the first to use accelerometry to explore
activity levels and health status among older adults with
mobility limitations. While public health guidelines recom-
mended 150 minutes of moderate to vigorous activity per
week, many individuals in this population are unable to
participate in this level of activity.
Conclusions
Previous studies10,22 and the current findings show that lower
levels of activity may be potentially warranted, as there are
health benefits related to the amount of activity individuals in
this population may be capable of engaging. While accelerom-
eters are an expensive research tool that produce data which
may be difficult for a member of the general population to
interpret, pedometers are a low cost and easy-to-use
alternative device for individuals to clinically monitor their
daily activity duration and step count. While accelerometry
could potentially be used as an additional vital sign to aid in
clinical guidance for determining overall health and risk, more
research is ultimately needed to interpret accelerometry data
on an individual level and for provision of recommendations in
a clinical setting.
Appendix
LIFE Study Research Group
Contributors
Administrative Coordinating Center, University of Florida,
Gainesville, FL: Marco Pahor, MD—Principal Investigator of
the LIFE Study; Jack M. Guralnik, MD, PhD—Co-Investigator of
the LIFE study (University of Maryland School of Medicine,
Baltimore, MD); Christiaan Leeuwenburgh, PhD; Connie
Caudle; Lauren Crump, MPH; Latonia Holmes; Jocelyn Lee,
PhD; Ching-ju Lu, MPH.
Data Management, Analysis and Quality Control Center,
Wake Forest University, Winston Salem, NC: Michael E. Miller,
PhD—DMAQC Principal Investigator; Mark A. Espeland, PhD
—DMAQC Co-Investigator; Walter T. Ambrosius, PhD; William
Applegate, MD; Daniel P. Beavers, PhD, MS; Robert P.
Byington, PhD, MPH, FAHA; Delilah Cook, CCRP; Curt D.
Furberg, MD, PhD; Lea N. Harvin, BS; Leora Henkin, MPH,
Med; John Hepler, MA; Fang-Chi Hsu, PhD; Laura Lovato, MS;
Wesley Roberson, BSBA; Julia Rushing, BSPH, MStat; Scott
Rushing, BS; Cynthia L. Stowe, MPM; Michael P. Walkup, MS;
Don Hire, BS; W. Jack Rejeski, PhD; Jeffrey A. Katula, PhD, MA;
Peter H. Brubaker, PhD; Shannon L. Mihalko, PhD; Janine M.
Jennings, PhD; Shyh-Huei Chen, PhD; June J. Pierce, AB.
National Institutes of Health, Bethesda, MD: Evan C. Hadley,
MD (National Institute on Aging); Sergei Romashkan, MD, PhD
(National Institute on Aging); Kushang V. Patel, PhD (National
Institute on Aging).
National Heart, Lung and Blood Institute, Bethesda, MD:
Denise Bonds, MD, MPH.
Field Centers
Northwestern University, Chicago, IL: Mary M. McDermott,
MD—Field Center Principal Investigator; Bonnie Spring, PhD
—Field Center Co-Investigator; Joshua Hauser, MD—Field
Center Co-Investigator; Diana Kerwin, MD—Field Center Co-
Investigator; Kathryn Domanchuk, BS; Rex Graff, MS; Alvito
Rego, MA.
Pennington Biomedical Research Center, Baton Rouge, LA:
Timothy S. Church, MD, PhD, MPH—Field Center Principal
Investigator; Steven N. Blair, PED (University of South
Carolina); Valerie H. Myers, PhD; Ron Monce, PA-C; Nathan
E. Britt, NP; Melissa Nauta Harris, BS; Ami Parks McGucken,
MPA, BS; Ruben Rodarte, MBA, MS, BS; Heidi K. Millet, MPA,
BS; Catrine Tudor-Locke, PhD, FACSM; Ben P. Butitta, BS;
Sheletta G. Donatto, MS, RD, LDN, CDE; Shannon H.
Cocreham, BS.
Stanford University, Palo Alto, CA: Abby C. King, PhD—Field
Center Principal Investigator; Cynthia M. Castro, PhD; William
L. Haskell, PhD; Randall S. Stafford, MD, PhD; Leslie A. Pruitt,
PhD; Kathy Berra, MSN, NP-C, FAAN; Veronica Yank, MD.
Tufts University, Boston, MA: Roger A. Fielding, PhD—Field
Center Principal Investigator; Miriam E. Nelson, PhD—Field
Center Co-Investigator; Sara C. Folta, PhD—Field Center Co-
Investigator; Edward M. Phillips, MD; Christine K. Liu, MD;
Erica C. McDavitt, MS; Kieran F. Reid, PhD, MPH; Dylan R.
Kirn, BS; Evan P. Pasha, BS; Won S. Kim, BS; Vince E. Beard,
BS; Eleni X. Tsiroyannis, BS; Cynthia Hau, BS, MPH.
University of Florida, Gainesville, FL: Todd M. Manini, PhD—
Field Center Principal Investigator; Marco Pahor, MD—Field
Center Co-Investigator; Stephen D. Anton, PhD; Susan Nay-
field, MD; Thomas W. Buford, PhD; Michael Marsiske, PhD;
Bhanuprasad D. Sandesara, MD; Jeffrey D. Knaggs, BS; Megan
S. Lorow, BS; William C. Marena, MT, CCRC; Irina Korytov, MD;
DOI: 10.1161/JAHA.117.007215 Journal of the American Heart Association 8
Aging, Physical Activity, and Cardiovascular Events Cochrane et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
Holly L. Morris, MSN, RN, CCRC (Brooks Rehabilitation Clinical
Research Center, Jacksonville, FL); Margo Fitch, PT (Brooks
Rehabilitation Clinical Research Center, Jacksonville, FL); Floris
F. Singletary, MS, CCC-SLP (Brooks Rehabilitation Clinical
Research Center, Jacksonville, FL); Jackie Causer, BSH, RN
(Brooks Rehabilitation Clinical Research Center, Jacksonville,
FL); Katie A. Radcliff, MA (Brooks Rehabilitation Clinical
Research Center, Jacksonville, FL).
University of Pittsburgh, Pittsburgh, PA: Anne B. Newman,
MD, MPH—Field Center Principal Investigator; Stephanie A.
Studenski, MD, MPH– Field Center Co-Investigator; Bret H.
Goodpaster, PhD; Nancy W. Glynn, PhD; Oscar Lopez, MD;
Neelesh K. Nadkarni, MD, PhD; Kathy Williams, RN, BSEd,
MHSA; Mark A. Newman, PhD; George Grove, MS; Janet T.
Bonk, MPH, RN; Jennifer Rush, MPH; Piera Kost, BA
(deceased); Diane G. Ives, MPH.
Wake Forest University, Winston Salem, NC: Stephen B.
Kritchevsky, PhD—Field Center Principal Investigator;
Anthony P. Marsh, PhD—Field Center Co-Investigator; Tina
E. Brinkley, PhD; Jamehl S. Demons, MD; Kaycee M. Sink, MD,
MAS; Kimberly Kennedy, BA, CCRC; Rachel Shertzer-Skinner,
MA, CCRC; Abbie Wrights, MS; Rose Fries, RN, CCRC;
Deborah Barr, MA, RHEd, CHES.
Yale University, New Haven, CT: Thomas M. Gill, MD—Field
Center Principal Investigator; Robert S. Axtell, PhD, FACSM—
Field Center Co-Investigator (Southern Connecticut State
University, Exercise Science Department); Susan S. Kashaf,
MD, MPH (VA Connecticut Healthcare System); Nathalie de
Rekeneire, MD, MS; Joanne M. McGloin, MDiv, MS, MBA;
Karen C. Wu, RN; Denise M. Shepard, RN, MBA; Barbara
Fennelly, MA, RN; Lynne P. Iannone, MS, CCRP; Raeleen
Mautner, PhD; Theresa Sweeney Barnett, MS, APRN; Sean N.
Halpin, MA; Matthew J. Brennan, MA; Julie A. Bugaj, MS; Maria
A. Zenoni, MS; Bridget M. Mignosa, AS.
Cognition Coordinating Center, Wake Forest University,
Winston Salem, NC: Jeff Williamson, MD, MHS—Center
Principal Investigator; Kaycee M. Sink, MD, MAS—Center
Co-Investigator; Hugh C. Hendrie, MB, ChB, DSc (Indiana
University); Stephen R. Rapp, PhD; Joe Verghese, MB, BS
(Albert Einstein College of Medicine of Yeshiva University);
Nancy Woolard; Mark Espeland, PhD; Janine Jennings, PhD;
Valerie K. Wilson, MD.
Electrocardiogram Reading Center, University of Florida,
Gainesville, FL: Carl J. Pepine MD, MACC; Mario Ariet, PhD;
Eileen Handberg, PhD, ARNP; Daniel Deluca, BS; James Hill,
MD, MS, FACC; Anita Szady, MD.
Spirometry Reading Center, Yale University, New Haven, CT:
Geoffrey L. Chupp, MD; Gail M. Flynn, RCP, CRFT; Thomas M.
Gill, MD; John L. Hankinson, PhD (Hankinson Consulting, Inc.);
Carlos A. Vaz Fragoso, MD.
Cost Effectiveness Analysis Center: Erik J. Groessl, PhD
(University of California, San Diego and VA San Diego
Healthcare System); Robert M. Kaplan, PhD (Office of
Behavioral and Social Sciences Research, National Institutes
of Health).
Sources of Funding
The LIFE study is funded by a National Institutes of Health/
National Institute on Aging Cooperative Agreement #U01
AG22376 and a supplement from the National Heart, Lung,
and Blood Institute 3U01AG022376-05A2S, and sponsored in
part by the Intramural Research Program, National Institute on
Aging, NIH. The research is also partially supported by the
Claude D. Pepper Older Americans Independence Centers at
the University of Florida (1 P30 AG028740), Tufts University
(1P30AG031679), University of Pittsburgh (P30 AG024827),
Wake Forest University (P30AG021332), and Yale University
(P30AG021342) and the NIH/NCRR CTSA at Stanford
University (UL1 RR025744). Tufts University is also supported
by the Boston Rehabilitation Outcomes Center
(1R24HD065688-01A1). LIFE investigators are also partially
supported by the following: Dr Thomas Gill (Yale University) is
the recipient of an Academic Leadership Award (K07AG3587)
from the National Institute on Aging. Dr Carlos Fragoso
(Spirometry Reading Center, Yale University) is the recipient
of a Career Development Award from the Department of
Veterans Affairs. Dr Roger Fielding (Tufts University) is
partially supported by the US Department of Agriculture,
under agreement No. 58-1950-0-014. Any opinions, findings,
conclusion, or recommendations expressed in this publication
are those of the author(s) and do not necessarily reflect the
view of the US Department of Agriculture.
Disclosures
None.
References
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de
Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela
BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB,
McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K,
Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ,
Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW,
Turner MB; American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Executive summary: heart disease and stroke
statistics—2015 update: a report from the American Heart Association.
Circulation. 2015;131:434–441.
2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de
Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela
BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB,
McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K,
Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ,
Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW,
Turner MB; American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a
report from the American Heart Association. Circulation. 2015;131:e29–e322.
3. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory
diseases: opportunities for reducing national health expenditures. Med Care.
1999;37:994–1012.
DOI: 10.1161/JAHA.117.007215 Journal of the American Heart Association 9
Aging, Physical Activity, and Cardiovascular Events Cochrane et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
4. Ortman J, Velkoff V, Hogan H. An aging nation: the older population in the
United States. 2014;P25-1140.
5. Luke A, Dugas LR, Durazo-Arvizu RA, Cao G, Cooper RS. Assessing physical
activity and its relationship to cardiovascular risk factors: NHANES 2003–
2006. BMC Public Health. 2011;11:387.
6. US Department of Health and Human Services. Physical activity guidelines
advisory committee report, 2008. To the secretary of health and human
services. Nutr Rev. 2009;67:114–120.
7. Newman AB, Dodson JA, Church TS, Buford TW, Fielding RA, Kritchevsky S,
Beavers D, Pahor M, Stafford RS, Szady AD, Ambrosius WT, McDermott MM;
LIFE Study Group. Cardiovascular events in a physical activity intervention
compared with a successful aging intervention: the LIFE Study randomized
trial. JAMA Cardiol. 2016;1:568–574.
8. Taraldsen K, Chastin SF, Riphagen II, Vereijken B, Helbostad JL. Physical
activity monitoring by use of accelerometer-based body-worn sensors in older
adults: a systematic literature review of current knowledge and applications.
Maturitas. 2012;71:13–19.
9. Falck RS, McDonald SM, Beets MW, Brazendale K, Liu-Ambrose T. Measure-
ment of physical activity in older adult interventions: a systematic review. Br J
Sports Med. 2016;50:464–470.
10. Fitzgerald JD, Johnson L, Hire DG, Ambrosius WT, Anton SD, Dodson JA, Marsh
AP, McDermott MM, Nocera JR, Tudor-Locke C, White DK, Yank V, Pahor M,
Manini TM, Buford TW; LIFE Study Research Group. Association of objectively
measured physical activity with cardiovascular risk in mobility-limited older
adults. J Am Heart Assoc. 2015;4:e001288. DOI: 10.1161/JAHA.114.001288.
11. Fielding RA, Rejeski WJ, Blair S, Church T, Espeland MA, Gill TM, Guralnik JM,
Hsu FC, Katula J, King AC, Kritchevsky SB, McDermott MM, Miller ME, Nayfield
S, Newman AB, Williamson JD, Bonds D, Romashkan S, Hadley E, Pahor M;
LIFE Research Group. The lifestyle interventions and independence for elders
study: design and methods. J Gerontol A Biol Sci Med Sci. 2011;66:
1226–1237.
12. Marsh AP, Lovato LC, Glynn NW, Kennedy K, Castro C, Domanchuk K,
McDavitt E, Rodate R, Marsiske M, McGloin J, Groessl EJ, Pahor M, Guralnik
JM; LIFE Study Research Group. Lifestyle interventions and independence for
elders study: recruitment and baseline characteristics. J Gerontol A Biol Sci
Med Sci. 2013;68:1549–1558.
13. Rejeski WJ, Axtell R, Fielding R, Katula J, King AC, Manini TM, Marsh AP, Pahor
M, Rego A, Tudor-Locke C, Newman M, Walkup MP, Miller ME; LIFE Study
Investigator Group. Promoting physical activity for elders with compromised
function: the lifestyle interventions and independence for elders (LIFE) study
physical activity intervention. Clin Interv Aging. 2013;8:1119–1131.
14. Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, Espeland
MA, Fielding RA, Gill TM, Groessl EJ, King AC, Kritchevsky SB, Manini TM,
McDermott MM, Miller ME, Newman AB, Rejeski WJ, Sink KM, Williamson JD;
LIFE Study Investigators. Effect of structured physical activity on prevention of
major mobility disability in older adults: the LIFE study randomized clinical
trial. JAMA. 2014;311:2387–2396.
15. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc.
1982;14:377–381.
16. Choi L, Liu Z, Matthews CE, Buchowski MS. Validation of accelerometer wear
and nonwear time classification algorithm. Med Sci Sports Exerc.
2011;43:357–364.
17. Ekelund U, Luan J, Sherar LB, Esliger DW, Griew P, Cooper A; International
Children’s Accelerometry Database (ICAD) Collaborators. Moderate to vigor-
ous physical activity and sedentary time and cardiometabolic risk factors in
children and adolescents. JAMA. 2012;307:704–712.
18. Therneau T, ed. A Package for Survival Analysis in S. Version 2.38. 2015.
https://CRAN.R-project.org/package=survival.
19. Exercise for health. WHO/FIMS committee on physical activity for health. Bull
World Health Organ. 1995;73:135–136.
20. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS,
Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith
SC Jr, Svetkey LP, Wadden TA, Yanovski SZ; American College of
Cardiology/American Heart Association Task Force on Practice Guidelines.
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular
risk: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines. J Am Coll Cardiol.
2014;63:2960–2984.
21. Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM,
Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP,
Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard
VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC,
Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J,
Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD,
Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF,
Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2
diabetes. N Engl J Med. 2013;369:145–154.
22. Mankowski RT, Anton SD, Axtell R, Chen SH, Fielding RA, Glynn NW, Hsu FC,
King AC, Layne AS, Leeuwenburgh C, Manini TM, Marsh AP, Pahor M, Tudor-
Locke C, Conroy DE, Buford TW. Device-measured physical activity as a
predictor of disability in mobility-limited older adults. J Am Geriatr Soc.
2017;65:2251–2256.
DOI: 10.1161/JAHA.117.007215 Journal of the American Heart Association 10
Aging, Physical Activity, and Cardiovascular Events Cochrane et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
